Kestra Medical Reports 63% Revenue Growth Amid VA and Medicaid Expansion
Kestra Medical (KMTS) delivered a robust Q3 2026 with $24.6 million in revenue, driven by a 58% surge in Assure system prescriptions. Despite a widening net loss of $34.2 million, the company secured critical access to the VA Federal Supply Schedule and expanded its Florida Medicaid footprint.